Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety.

Elisete Isabel CroccoLiliana TorloniPaula Bonilha FernandesMaria Elisa Barbosa Bueno de CamposMaura GonzagaFernanda Cristina SilvaJoão Paulo Sardin NasarioLucas Offenbecker GuerraAngélica Richart CsipakVivienne Carduz Castilho

Published in: Journal of cosmetic dermatology (2024)

A combination cream comprising 5% cysteamine and 4% nicotinamide was effective, tolerable, and safe for treating melasma.

Keyphrases

open label
randomized controlled trial
clinical trial
double blind